SEC Form SC 13G/A filed by Cactus Acquisition Corp. 1 Limited (Amendment)

$CCTS
Blank Checks
Finance
Get the next $CCTS alert in real time by email
SC 13G/A 1 ea0206693-13ga1cact_cactus1.htm AMENDMENT NO. 1 TO SCHEDULE 13G
 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

  

SCHEDULE 13G/A

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO § 240.13d-2

 

(Amendment No. 1)*

 

Cactus Acquisition Corp 1 Ltd.

(Name of Issuer)

 

Class A ordinary shares, par value $0.0001 per share

(Title of Class of Securities)

 

G1745A108**

(CUSIP Number)

 

February 23, 2024

 

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  Rule 13d-1(b)

 

  Rule 13d-1(c)

 

  Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No. G1745A108 13G/A Page 2 of 8 Pages

 

1.

Names of Reporting Persons

 

Cactus Healthcare Management LP

2.

Check the Appropriate Box if a Member of a Group

(See Instructions)

(a) ☐          

(b) ☐          

3.

SEC USE ONLY

 

4.

Citizenship or Place of Organization

 

Delaware

  

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person with

5.

Sole Voting Power

 

632,501 (1)

6.

Shared Voting Power

 

0

7.

Sole Dispositive Power

 

632,501 (1)

8.

Shared Dispositive Power

 

0

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person

 

632,501 (1)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐

 

11.

Percent of Class Represented by Amount in Row (9)

 

12.5% (2)

12.

Type of Reporting Person (See Instructions)

 

PN

 

(1) Excludes 973,333 Class A ordinary shares underlying warrants held by the Reporting Person, which are not exercisable as of, or within 60 days of, the date of this Schedule 13G/A.
(2) The percentage of Class A ordinary shares is calculated based upon 5,074,870 Class A Ordinary Shares reported to be outstanding as of May 15, 2024, as reported in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended on March 31, 2024, filed with the Securities and Exchange Commission (the “Commission”) on May 15, 2024.

 

 

 

 

CUSIP No. G1745A108 13G/A Page 3 of 8 Pages

 

1.

Names of Reporting Persons

 

Cactus Healthcare Management LLC

2.

Check the Appropriate Box if a Member of a Group

(See Instructions)

(a) ☐          

(b) ☐          

3.

SEC USE ONLY

 

4.

Citizenship or Place of Organization

 

Delaware

 

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person with

5.

Sole Voting Power

 

0

6.

Shared Voting Power

 

632,501 (1)

7.

Sole Dispositive Power

 

0

8.

Shared Dispositive Power

 

632,501 (1)

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person

 

632,501 (1)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐

 

11.

Percent of Class Represented by Amount in Row (9)

 

12.5% (2)

12.

Type of Reporting Person (See Instructions)

 

PN

 

(1) Consists of 632,501 Class A ordinary shares held by Cactus Healthcare Management LP (for which the Reporting Person serves as sole general partner). Excludes 973,333 Class A ordinary shares underlying warrants held by Cactus Healthcare Management LP, which are not exercisable as of, or within 60 days of, the date of this Schedule 13G/A.
(2) The percentage of Class A ordinary shares is calculated based upon 5,074,870 Class A ordinary shares reported to be outstanding as of May 15, 2024, as reported in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended on March 31, 2024, filed with the Commission on May 15, 2024.

 

 

 

 

CUSIP No. G1745A108 13G/A Page 4 of 8 Pages

 

Item 1(a). Name of Issuer:

 

The name of the issuer is Cactus Acquisition Corp. 1 Limited (the “Issuer”).

   

 

Item 1(b). Address of Issuer’s Principal Executive Offices:

 

The Issuer’s principal executive offices are located at 4B Cedar Brook Drive, Cranbury, NJ 08512.

   

 

Item 2(a). Name of Person Filing:

 

The following entities, listed in (i) and (ii) below, who are filing this Amendment No. 1 (this “Amendment”) to the Statement of Beneficial Ownership on Schedule 13G filed on March 21, 2022 (the “Statement”), are referred to herein collectively as the “Reporting Persons”:

 

  (i) Cactus Healthcare Management LP (the “Sponsor”)
  (ii) Cactus Healthcare Management LLC (the “GP”)

 

The Sponsor directly holds the securities of the Issuer that are reported in this Statement. The GP serves as the sole general partner of the Sponsor and may therefore be deemed to share voting and investment authority with respect to the securities of the Issuer held thereby. Each of Hibotan LLC (an affiliate of Israel Biotech Fund), Kalistcare Limited (an affiliate of Consensus Business Group), and Clal Biotechnology Industries Cactus Ltd. (an affiliate of Clal Biotechnology Industries Ltd.) holds an equal 33.33% equity interest in the GP. No single entity or individual possesses the ability to control the voting or investment decisions made by the GP.

   

 

Item 2(b). Address of Principal Business Office or, if None, Residence:

 

The principal business office of each Reporting Person is c/o Cactus Acquisition Corp. 1 Limited, 4B Cedar Brook Drive, Cranbury, NJ 08512.

   

 

Item 2(c). Citizenship:

 

The citizenship or state of organization, as applicable, of each Reporting Person is as follows:

 

  (i) Sponsor— Delaware
  (ii) GP— Delaware
   

 

Item 2(d). Title of Class of Securities:

 

Class A ordinary shares, par value $0.0001 per share, of the Issuer (“Class A ordinary shares”).

   

 

Item 2(e). CUSIP Number:

 

The CUSIP number of the Class A ordinary shares is G1745A108.

   

 

 

 

 

CUSIP No. G1745A108 13G/A Page 5 of 8 Pages

 

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a:

 

  (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
       
  (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
       
  (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
       
  (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
       
  (e) An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
       
  (f) An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
       
  (g) A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
       
  (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
       
  (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
       
  (j) A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
       
  (k) Group, in accordance with §240.13d-1(b)(1)(ii)(K). 

 

If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: _________________

 

Not applicable.

   

 

Item 4. Ownership.

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  I. Cactus Healthcare Management LP

 

  (a) Amount beneficially owned: 632,501 (1)

 

  (b) Percent of class*: 12.5%

 

  (c) Number of shares as to which the person has:

 

  (i) Sole power to vote or to direct the vote: 632,501 (1)

 

  (ii) Shared power to vote or to direct the vote: 0

 

  (iii) Sole power to dispose of or to direct the disposition of: 632,501 (1) (2)

 

  (iv) Shared power to dispose of or to direct the disposition of: 0

 

  II. Cactus Healthcare Management LLC

 

  (a) Amount beneficially owned: 632,501 (1)

 

  (b) Percent of class*: 12.5%

 

 

 

 

CUSIP No. G1745A108 13G/A Page 6 of 8 Pages

 

  (c) Number of shares as to which the person has:

 

  (i) Sole power to vote or to direct the vote: 0

 

  (ii) Shared power to vote or to direct the vote: 632,501 (1)

 

  (iii) Sole power to dispose of or to direct the disposition of: 0

 

  (iv) Shared power to dispose of or to direct the disposition of: 632,501 (1)

  

* All percentage ownership information reflected in this Statement is based on 5,074,870 Class A ordinary shares reported to be outstanding as of May 15, 2024, as reported in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended on March 31, 2024, filed with the Commission on May 15, 2024.

 

(1) See the cover page for the applicable Reporting Person, which is incorporated by reference herein, for the explanation as to the basis for the beneficial ownership of these ordinary shares by the Reporting Person.

 

Each of the foregoing Reporting Persons disclaims beneficial ownership of the Class A ordinary shares reported herein except to the extent of its pecuniary interest (if any) therein.

   

 

Item 5. Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☐

   

 

Item 6. Ownership of More Than Five Percent on Behalf of Another Person.

 

Not applicable.

   

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

 

Not applicable.

   

 

Item 8. Identification and Classification of Members of the Group.  

 

Not applicable.

   

 

Item 9. Notice of Dissolution of Group.  

 

Not applicable.

   

 

Item 10. Certifications.  

 

Not applicable.

   

 

 

 

 

CUSIP No. G1745A108 13G/A Page 7 of 8 Pages

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  Cactus Healthcare Management LP
   
  By: Cactus Healthcare Management LLC, its sole General Partner

 

  By: /s/ Stephen T. Wills
    Name:  Stephen T. Wills
    Title: Secretary

 

  Cactus Healthcare Management LLC
     
  By: /s/ Stephen T. Wills
    Name: Stephen T. Wills
    Title: Secretary

 

Dated: May 23, 2024

 

 

 

 

CUSIP No. G1745A108 13G/A Page 8 of 8 Pages

 

EXHIBITS

 

Exhibit 1 Joint Filing Agreement pursuant to Rule 13d-1(k)(1) (incorporated by reference to Exhibit 1 to the Statement, filed with the Commission on March 18, 2022)

 

 

 

 

Get the next $CCTS alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CCTS

DatePrice TargetRatingAnalyst
More analyst ratings

$CCTS
Press Releases

Fastest customizable press release news feed in the world

See more
  • Tembo E-LV, a subsidiary of Nasdaq-listed VivoPower International PLC ("VVPR") executes a definitive Business Combination Agreement with CCTS for a combined enterprise value of US$904 million

    Independent third-party fairness opinion was obtained and satisfactorily completed Pro forma fully diluted combined enterprise value assumes no public trust redemptions LONDON, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Tembo E-LV B.V. ("Tembo"), a subsidiary of Nasdaq-listed B Corporation, VivoPower International PLC (NASDAQ:VVPR) ("VivoPower"), today announced that it has executed a definitive Business Combination Agreement ("BCA") with Cactus Acquisition Corp. 1 Limited, a Cayman Islands exempted special purpose acquisition company (NASDAQ:CCTS, CCTSW, CCTSU))) ("CCTS"). The BCA assigns a pro forma enterprise value to the combination of Tembo and CCTS, assuming no redemptions by CCTS publi

    $CCTS
    $VVPR
    Blank Checks
    Finance
    Power Generation
    Utilities
  • (UPDATED) VIVOPOWER'S TEMBO EXTENDS HEADS OF AGREEMENT EXCLUSIVITY FOR US$838M MERGER WITH CCTS

    Exclusivity period for Heads of Agreement extended to 31 August 2024 Extension to enable Tembo to consummate material transaction and update disclosure LONDON, July 30, 2024 (GLOBE NEWSWIRE) -- The Nasdaq-listed B Corp, VivoPower International PLC (NASDAQ:VVPR, "VivoPower"))), announced that its electric vehicle subsidiary, Tembo e-LV B.V. ("Tembo"), has agreed to a further one month extension of its exclusive heads of agreement with Nasdaq-listed Cactus Acquisition Corporation I (NASDAQ:CCTS, CCTSW, CCTSU, "CCTS"))) to 31 August 2024. The extension is intended to provide additional time for Tembo to consummate a material transaction and update disclosures before finalising a definitive

    $CCTS
    $VVPR
    Blank Checks
    Finance
    Power Generation
    Utilities
  • VIVOPOWER'S TEMBO EXTENDS HEADS OF AGREEMENT EXCLUSIVITY FOR US$838M MERGER WITH CCTS

    Exclusivity period for Heads of Agreement extended to 31 August 2024 Extension to enable Tembo to consummate material transaction and update disclosure LONDON, July 29, 2024 (GLOBE NEWSWIRE) -- The Nasdaq-listed B Corp, VivoPower International PLC (NASDAQ:VVPR, "VivoPower"))), announced today that its electric vehicle subsidiary, Tembo e-LV B.V. ("Tembo"), has agreed to a further one month extension of its exclusive heads of agreement with Nasdaq-listed Cactus Acquisition Corporation I (NASDAQ:CCTS, CCTSW, CCTSU, "CCTS"))) to 31 August 2024. The extension is intended to provide additional time for Tembo to consummate a material transaction and update disclosures before finalising a defi

    $CCTS
    $VVPR
    Blank Checks
    Finance
    Power Generation
    Utilities

$CCTS
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$CCTS
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$CCTS
SEC Filings

See more

$CCTS
Leadership Updates

Live Leadership Updates

See more
  • MediWound Announces CEO Transition

    Ofer Gonen, current Board member and CEO of Clal Biotechnology Industries Ltd., appointed as New CEO – Effective June 30 Will replace current CEO Sharon Malka, who will join the Board of Directors YAVNE, Israel, May 17, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced the appointment of Ofer Gonen as Chief Executive Officer (CEO) of MediWound as of June 30, 2022, succeeding Sharon Malka, who will join the Company's Board of Directors. Ofer Gonen has been a board member in MediWound and the CEO of Clal Biotechnology Industries, Ltd. ("C

    $CCTS
    $GMDA
    $MDWD
    Blank Checks
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

$CCTS
Financials

Live finance-specific insights

See more
  • VivoPower announces binding heads of agreement to merge Tembo into NASDAQ listed CCTS at an indicative US$838m Equity Value

    Tembo E-LV ("Tembo"), a subsidiary of VivoPower International PLC ("VivoPower"), will merge with CCTS ("Cactus Acquisition Corp. 1 Limited"), a NASDAQ-listed company. Tembo will be the surviving entity and upon closing, will change its name to Tembo Group. CCTS has $25m of cash on its balance sheet, as of its last quarterly filing. VivoPower shareholders on the final record date will receive 5 Tembo Group shares for each 1 VivoPower share held. Final Business Combination Agreement, an independent fairness opinion to be finalised by early May 2024 with the merger targeted for completion by August 2024 LONDON, April 02, 2024 (GLOBE NEWSWIRE) -- Tembo, a global leader in utility vehicle

    $CCTS
    $VVPR
    Blank Checks
    Finance
    Power Generation
    Utilities

$CCTS
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more